Impact of antiviral treatment on long-term prognosis in non-immunocompromised patients with CMV reactivation
Abstract Background Reactivation of human cytomegalovirus (CMV) occurs in non-immunocompromised patients with or without specific organ involvement, but it is still unknown whether it has a clinical implication on long-term prognosis or not. Methods A retrospective cohort study evaluating non-immuno...
Main Authors: | Ga Eun Park, Hyun Kyun Ki, Jae-Hoon Ko |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-021-06098-4 |
Similar Items
-
Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections
by: Swetha Pinninti, et al.
Published: (2023-10-01) -
Cytomegalovirus Retinitis in an Immunocompromised Infant:A Case Report and Review of the Literature
by: A. Mota, et al.
Published: (2011-08-01) -
Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events
by: Ralph Rogers, et al.
Published: (2020-01-01) -
Experience of Using the Antiviral Therapy of Generalized Congenital Cytomegalovirus Infection
by: G. V. Petrova, et al.
Published: (2016-06-01) -
CMV and HSV-2 myeloradiculitis in an HIV infected patient
by: Adriana Pinto, et al.
Published: (2011-06-01)